Back to search results

Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Ovarian Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • M D Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Shannon Westin, MD) · swestin@mdanderson.org · 713-794-4314
    Contact: Principal Investigator (Shannon Westin, MD)
Study leads

  • Shannon Westin, MD

    Principal Investigator

    M.D. Anderson Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)